1. Home
  2. NSSC vs EVO Comparison

NSSC vs EVO Comparison

Compare NSSC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NAPCO Security Technologies Inc.

NSSC

NAPCO Security Technologies Inc.

HOLD

Current Price

$38.01

Market Cap

1.4B

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.41

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSSC
EVO
Founded
1969
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NSSC
EVO
Price
$38.01
$3.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$47.50
$7.00
AVG Volume (30 Days)
306.4K
213.1K
Earning Date
02-03-2026
11-05-2025
Dividend Yield
1.45%
N/A
EPS Growth
N/A
N/A
EPS
1.23
N/A
Revenue
$186,786,000.00
$887,396,457.00
Revenue This Year
$13.13
N/A
Revenue Next Year
$9.55
$8.52
P/E Ratio
$31.39
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.00
$2.84
52 Week High
$48.12
$4.80

Technical Indicators

Market Signals
Indicator
NSSC
EVO
Relative Strength Index (RSI) 33.56 50.67
Support Level $39.20 $3.58
Resistance Level $43.19 $3.66
Average True Range (ATR) 1.29 0.08
MACD -0.44 0.02
Stochastic Oscillator 7.73 40.82

Price Performance

Historical Comparison
NSSC
EVO

About NSSC NAPCO Security Technologies Inc.

NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: